Search research articles
Contact Us
Filters
Showing results (101-110 of 520) with videos related to
Page
of 52
Sort By:
The American Journal of Medicine
|
June 22, 2013
Emerging clinical challenges in the use of statins
Charles H Hennekens, Nicolas R Breuer, Ira J Gelb, et al.
Clinical Trials (London, England)
|
August 24, 2012
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study
Lihui Zhao, Lu Tian, Hajime Uno, et al.
Journal of the American College of Cardiology
|
November 27, 2007
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy
Stefan H Hohnloser, Dimitri Pajitnev, Janice Pogue, et al.
European Heart Journal
|
July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
Jeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.
Biometrics
|
August 25, 2015
On the restricted mean survival time curve in survival analysis
Lihui Zhao, Brian Claggett, Lu Tian, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
January 21, 2006
Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experience
Nagesh S Anavekar, Atique Mirza, Hicham Skali, et al.
JAMA Cardiology
|
December 1, 2021
Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review
Zachary R McCaw, Brian Lee Claggett, Lu Tian, et al.
European Journal of Heart Failure
|
August 2, 2005
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis
Jawdat Abdulla, Janice Pogue, Steen Z Abildstrøm, et al.
Transplantation
|
September 23, 2025
Safety and Tolerability of Sotagliflozin Among Kidney Transplant Recipients
Martina M McGrath, Finnian R Mc Causland, Brian L Claggett, et al.
European Journal of Heart Failure
|
November 11, 2003
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)
Jay N Cohn, Marc A Pfeffer, Jean Rouleau, et al.
Page
of 52
Search research articles
Search
Showing results (101-110 of 520) with videos related to
Sort By:
Page
of 52
The American Journal of Medicine
|
June 22, 2013
Emerging clinical challenges in the use of statins
Charles H Hennekens, Nicolas R Breuer, Ira J Gelb, et al.
Clinical Trials (London, England)
|
August 24, 2012
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study
Lihui Zhao, Lu Tian, Hajime Uno, et al.
Journal of the American College of Cardiology
|
November 27, 2007
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy
Stefan H Hohnloser, Dimitri Pajitnev, Janice Pogue, et al.
European Heart Journal
|
July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
Jeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.
Biometrics
|
August 25, 2015
On the restricted mean survival time curve in survival analysis
Lihui Zhao, Brian Claggett, Lu Tian, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
January 21, 2006
Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experience
Nagesh S Anavekar, Atique Mirza, Hicham Skali, et al.
JAMA Cardiology
|
December 1, 2021
Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review
Zachary R McCaw, Brian Lee Claggett, Lu Tian, et al.
European Journal of Heart Failure
|
August 2, 2005
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis
Jawdat Abdulla, Janice Pogue, Steen Z Abildstrøm, et al.
Transplantation
|
September 23, 2025
Safety and Tolerability of Sotagliflozin Among Kidney Transplant Recipients
Martina M McGrath, Finnian R Mc Causland, Brian L Claggett, et al.
European Journal of Heart Failure
|
November 11, 2003
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)
Jay N Cohn, Marc A Pfeffer, Jean Rouleau, et al.
Page
of 52